Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Koelblen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Analytical Biochemistry|April 6, 2025
Development of radioligand binding assays for REV-ERBα and REV-ERBβThomas Koelblen, Elise P Burris, Thomas P Burris
Organic & Biomolecular Chemistry|July 18, 2025
Iodine-promoted oxidative cross-coupling for the synthesis of (<i>E</i>)-2-(3-oxo-3-phenylprop-1-en-1-yl)-3-phenylquinazolin-4(3<i>H</i>)-one <i>via</i> C-H activation: development of synthetic TLX agonistsLingaiah Maram, Puhan Zhao, Thomas Koelblen, et al.
Organic Letters|May 18, 2022
Progress toward the De Novo Asymmetric Synthesis of EuphanesHtooTint Wai, Thomas Koelblen, Matthew E Hayes, et al.
Cell Communication and Signaling : CCS|October 12, 2014
The Brucella TIR domain containing proteins BtpA and BtpB have a structural WxxxE motif important for protection against microtubule depolymerisationChristine Felix, Burcu Kaplan Türköz, Sebastien Ranaldi, et al.
FEBS Letters|October 1, 2013
Structure of the Toll/interleukin 1 receptor (TIR) domain of the immunosuppressive Brucella effector BtpA/Btp1/TcpBBurcu Kaplan-Türköz, Thomas Koelblen, Christine Felix, et al.
ACS Central Science|March 4, 2024
From Functional Fatty Acids to Potent and Selective Natural-Product-Inspired Mimetics via Conformational ProfilingLauren E Markham, Thomas Koelblen, Harry R Chobanian, et al.
Journal of Medicinal Chemistry|September 6, 2024
Merging Natural Product Structures with Pharmaceutical Leads: Unnatural Enantiomers of Estranes as Glucocorticoid Receptor Modulators That Suppress TNF-α and IL-6 ReleaseJoshua M Nicholson, Dexi Yang, Thomas Koelblen, et al.
Nature Communications|November 22, 2022
Structural basis of synthetic agonist activation of the nuclear receptor REV-ERBMeghan H Murray, Aurore Cecile Valfort, Thomas Koelblen, et al.
Cell Chemical Biology|August 9, 2020
The Orphan Nuclear Receptor TLX Is a Receptor for Synthetic and Natural RetinoidsKristine Griffett, Gonzalo Bedia-Diaz, Lamees Hegazy, et al.
The FEBS Journal|October 22, 2017
Molecular dissection of protein-protein interactions between integrin α5β1 and the Helicobacter pylori Cag type IV secretion systemThomas Koelblen, Célia Bergé, Mickaël V Cherrier, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Analytical Biochemistry|April 6, 2025
Development of radioligand binding assays for REV-ERBα and REV-ERBβThomas Koelblen, Elise P Burris, Thomas P Burris
Organic & Biomolecular Chemistry|July 18, 2025
Iodine-promoted oxidative cross-coupling for the synthesis of (<i>E</i>)-2-(3-oxo-3-phenylprop-1-en-1-yl)-3-phenylquinazolin-4(3<i>H</i>)-one <i>via</i> C-H activation: development of synthetic TLX agonistsLingaiah Maram, Puhan Zhao, Thomas Koelblen, et al.
Organic Letters|May 18, 2022
Progress toward the De Novo Asymmetric Synthesis of EuphanesHtooTint Wai, Thomas Koelblen, Matthew E Hayes, et al.
Cell Communication and Signaling : CCS|October 12, 2014
The Brucella TIR domain containing proteins BtpA and BtpB have a structural WxxxE motif important for protection against microtubule depolymerisationChristine Felix, Burcu Kaplan Türköz, Sebastien Ranaldi, et al.
FEBS Letters|October 1, 2013
Structure of the Toll/interleukin 1 receptor (TIR) domain of the immunosuppressive Brucella effector BtpA/Btp1/TcpBBurcu Kaplan-Türköz, Thomas Koelblen, Christine Felix, et al.
ACS Central Science|March 4, 2024
From Functional Fatty Acids to Potent and Selective Natural-Product-Inspired Mimetics via Conformational ProfilingLauren E Markham, Thomas Koelblen, Harry R Chobanian, et al.
Journal of Medicinal Chemistry|September 6, 2024
Merging Natural Product Structures with Pharmaceutical Leads: Unnatural Enantiomers of Estranes as Glucocorticoid Receptor Modulators That Suppress TNF-α and IL-6 ReleaseJoshua M Nicholson, Dexi Yang, Thomas Koelblen, et al.
Nature Communications|November 22, 2022
Structural basis of synthetic agonist activation of the nuclear receptor REV-ERBMeghan H Murray, Aurore Cecile Valfort, Thomas Koelblen, et al.
Cell Chemical Biology|August 9, 2020
The Orphan Nuclear Receptor TLX Is a Receptor for Synthetic and Natural RetinoidsKristine Griffett, Gonzalo Bedia-Diaz, Lamees Hegazy, et al.
The FEBS Journal|October 22, 2017
Molecular dissection of protein-protein interactions between integrin α5β1 and the Helicobacter pylori Cag type IV secretion systemThomas Koelblen, Célia Bergé, Mickaël V Cherrier, et al.
Pageof 2